1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: The following table provides information on the Company’s share repurchases during the first quarter of fiscal 2026:
+Added: The following table provides information on the Company’s share repurchases during the second quarter of fiscal 2026:
Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Program Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (1)(2)
−Removed: (Dollars in Thousands, Except Shares and Per Share Data)
−Removed: March 30, 2025 – April 26, 2025 363,886 (2)
−Removed: April 27, 2025 – May 24, 2025 — — — —
−Removed: May 25, 2025 – June 28, 2025 — — — —
+Added: (Dollars in Thousands, Except Per Share Data)
+Added: June 29, 2025 – July 26, 2025 — — — $ 500,000
+Added: July 27, 2025 – August 23, 2025 1,113,586 $ 53.88 1,113,586 $ 425,000
+Added: August 24, 2025 – September 27, 2025 316,993 $ 47.32 316,993 $ 425,000
Total 1,430,579 1,430,579
−Removed: (1) In August 2022, our Board approved a three-year share repurchase program authorizing the repurchase of up to $300.0 million of Haemonetics common stock, based on market conditions, through August 2025.
+Added: (1) In April 2025, our Board approved a three-year share repurchase program authorizing the repurchase of up to $500.0 million of Haemonetics common stock, based on market conditions, through April 2028.
Under the 2025 share repurchase program, shares may be repurchased in accordance with applicable laws both on the open market, including under trading plans established pursuant to Rule 10b5-1 under the Exchange Act, and in privately negotiated transactions.
−Removed: (2) In April 2025, the Company completed a $150.0 million repurchase of its common stock pursuant to an accelerated share repurchase agreement (“ASR”) entered into with Goldman Sachs & Co.
−Removed: in February 2025.
+Added: (2) In September 2025, we completed a $75.0 million repurchase of our common stock pursuant to an ASR entered into with Citibank in August 2025.
The total number of shares repurchased under the ASR was 1,430,579 at an average price per share upon final settlement of $52.43.
−Removed: As of March 29, 2025, the Company had fully funded the $300.0 million authorization under its 2022 share repurchase program.
+Added: As of September 27, 2025, the total remaining authorization for repurchases of our common stock under the share repurchase program was $425.0 million.
Defaults Upon Senior Securities
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.